financetom
Business
financetom
/
Business
/
BP partially restarts Olympic Pipeline after leak identified
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BP partially restarts Olympic Pipeline after leak identified
Nov 25, 2025 12:03 PM

*

BP confirms leak in 20-inch segment, repairs planned

*

Washington and Oregon declared fuel emergency due to

closure

*

Shutdown disrupted fuel supplies to Seattle-Tacoma Airport

(Adds latest updates from Delta Air Lines ( DAL ) and Alaska Airlines

in paragraph 7-9)

By Nicole Jao

NEW YORK, Nov 25 (Reuters) - BP said on Tuesday

it had partially restarted the 400-mile Olympic Pipeline after

crews identified the source of a leak of refined products east

of Everett, Washington.

Washington declared a fuel emergency last week and Oregon

followed suit on Monday in response to the system shutdown,

which has disrupted jet fuel supplies to Seattle-Tacoma

International Airport.

The Olympic Pipeline moves refined petroleum products including

gasoline, diesel and jet fuel from northern Washington to Oregon

and consists of one 16-inch diameter pipeline and one 20-inch

pipeline.

Crews restored the 16-inch segment of the pipeline system on

Tuesday morning after finding no indications of a leak, BP said

in an emailed statement. After conducting tests, they were able

to confirm a leak in the 20-inch segment and repairs are being

planned.

BP did not provide timelines for repair of the 20-inch pipe

and the full restart of the system.

A refined products discharge on the Olympic Pipeline was first

reported on November 11. BP shut the entire pipeline system a

week later, halting product deliveries.

Major carriers including Alaska Airlines and Delta Air

Lines ( DAL ) have implemented plans to minimize the impact of

the pipeline disruption on flights out of Seattle-Tacoma

International Airport during the busy Thanksgiving travel week

by hauling extra fuel via tanker trucks and inbound flights and

adding fuel stops to outbound flights.

"Delta is operating our full Seattle hub schedule and has

discontinued fuel stops on select long-haul flights," the

carrier said on Tuesday.

"We have discontinued all planned fuel stops but will

continue to tanker and truck in additional fuel on a reduced

basis as the pipeline increases to normal capacity," Alaska

Airlines said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Aug 12, 2024
07:39 AM EDT, 08/12/2024 (MT Newswires) -- PS International ( PSIG ) shares surged 80% pre-bell Monday, extending Friday's rally. Veritone ( VERI ) advanced 18%, rebounding from Friday's slide. Nuburu ( BURU ) shares increased 7.3%, shaving losses from the previous session. Price: 3.6000, Change: +0.19, Percent Change: +5.57 ...
JetBlue Launches Senior Notes Offering, Term Loan
JetBlue Launches Senior Notes Offering, Term Loan
Aug 12, 2024
07:42 AM EDT, 08/12/2024 (MT Newswires) -- JetBlue Airways ( JBLU ) said Monday that it plans to offer $400 million of convertible senior notes due 2029. The carrier expects to grant initial purchasers a 13-day option to buy up to an additional $60 million of the notes. Net proceeds are expected to be used to repurchase a portion of...
Bitdeer Technologies Group's Q2 Loss Narrows, Revenue Rises
Bitdeer Technologies Group's Q2 Loss Narrows, Revenue Rises
Aug 12, 2024
07:36 AM EDT, 08/12/2024 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) reported a Q2 loss Monday of $0.14 per diluted share, narrower than its loss of $0.36 a year earlier. Analysts polled by Capital IQ expected earnings of $0.01. Revenue for the quarter ended June 30 was $99.2 million, compared with $93.8 million a year earlier. Analysts surveyed...
Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy
Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy
Aug 12, 2024
07:34 AM EDT, 08/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday the US Food and Drug Administration has approved Yorvipath, the company's treatment for hypoparathyroidism, a rare endocrine disease, in adults. The approval is based on data from the global phase 2 and 3 trials. The company said it is finalizing the manufacturing of a commercial product...
Copyright 2023-2026 - www.financetom.com All Rights Reserved